JPRN-UMIN000002396
Completed
Phase 2
Feasibility trial of neoadjuvant chemotherapy with docetaxel,cisplatin and fluorouracil for clinical stage II/III esophageal carcinoma. - neoadjuvant DCF for esophageal carcinoma
Saitama Cancer Center0 sites40 target enrollmentSeptember 1, 2009
Conditionsesophageal neoplasm
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- esophageal neoplasm
- Sponsor
- Saitama Cancer Center
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Simultaneous or metachronous (within 5 years) double cancers , with the exception of intramucosal tumor curable with local therapy 2\) Pregnant or lactating women or women of childbearing potential 3\) Psychosis 4\) Patients requiring systemic steroids medication 5\) HBs antigen positive 6\) Uncontrollable diabetes millutus 7\) History of myocardial infarction or unstable angina pectoris or interstitial pneumonia or fibroid lung or severe emphysema 8\) Active bacterial or fungous infection
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A feasibility study of neoadjuvant chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancerrectal cancerJPRN-UMIN000003428Toho University school of medicine20
Completed
Not Applicable
Feasibility study of neoadjuvant chemotherapy with docetaxel/CDGP/5-fluorouracil in resectable esophagus canceresophagus cancerJPRN-UMIN000014305Department of Medical Oncology, Sapporo Medical University School of Medicine28
Completed
Not Applicable
A feasibility study of neoadjuvant chemotherapy with docetaxel+cisplatin+capecitabine (DCX) for HER2-negative gastric cancer with macroscopic type 4 and large type 3, or with multiple lymph node metastasisGastric cancerJPRN-UMIN000026783agoya University20
Completed
Phase 1
Phase I/II trial of neoadjuvant chemotherapy with cisplatin and weekly paclitaxel in patients with stage Ib2- IIb uterine cervical cancerpatients with clinical stage Ib2, IIa(primary tumor diameter4 or more cm),IIb uterine cervical cancerJPRN-UMIN000002636Hyogo Cancer Center40
Recruiting
Phase 1
Phase I/II trial of neoadjuvant chemotherapy with UFT/Leucovorin and Irinotecan plus radiation in patients with locally advanced rectal cancer.ocally advanced rectal cancer with preoperative diagnosis of T3-4 and N0-3.JPRN-UMIN000006208The University of Tokyo Hospital. Department of surgical oncology.39